Tramadol Hydrochloride
Product Images NDC 45865-357

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label (357 90)

Package Label (357 90)
Tramadol Hydrochloride Tablets 50mg label for a 90-count bottle. Generic for Ultram, labeled by Medsource Pharmaceuticals. The label specifies tablet strength, form as white oval, film-coated, and includes lot and expiration details. It also carries warnings about dizziness, drowsiness, and alcohol avoidance in English and Spanish.*
FDA Label Image

Tramadol Hydrochloride Structural Formula (56dafd4d 6fa6 4579 8634 E02ec978c37b 01)

Tramadol Hydrochloride Structural Formula (56dafd4d 6fa6 4579 8634 E02ec978c37b 01)
Chemical structure diagram of tramadol hydrochloride, showing its molecular arrangement including cyclohexane and phenyl rings, hydroxyl group, methyl groups, and hydrochloride component.*
FDA Label Image

Figure 2 (56dafd4d 6fa6 4579 8634 E02ec978c37b 02)

Figure 2 (56dafd4d 6fa6 4579 8634 E02ec978c37b 02)
A line graph depicting the concentration of Tramadol and its metabolite M1 in ng/mL over time in hours up to 48 hours. The graph compares multiple and single doses for both Tramadol and M1, showing concentration decreasing over time.*
FDA Label Image

Figure 2: Protocol Capss-047 (56dafd4d 6fa6 4579 8634 E02ec978c37b 03)

Figure 2: Protocol Capss-047 (56dafd4d 6fa6 4579 8634 E02ec978c37b 03)
A line graph showing the percentage of subjects discontinuing over days in a double-blind study period, with a dosage labeled as '10 Days to 200 mg/day' tracked on the chart. The x-axis indicates days, and the y-axis indicates percent discontinuing, illustrating a gradual increase over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.